Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Bo Jensen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
JAMA Internal Medicine|April 1, 2020
Shift From Adalimumab Originator to Biosimilars in DenmarkThomas Bo Jensen, Seoyoung C Kim, Espen Jimenez-Solem, et al.
Journal of Diabetes Investigation|February 3, 2022
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trialsDaisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, et al.
The Bone & Joint Journal|September 30, 2021
Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort studyAstrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, et al.
Basic & Clinical Pharmacology & Toxicology|October 14, 2020
Validation of registration of pharmacological treatment in the Danish Hip and Knee Arthroplasty RegistersAstrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, et al.
Scientific Reports|March 7, 2020
Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 yearsDitte Resendal Gotfredsen, Siri Vinther, Tonny Studsgaard Petersen, et al.
Inflammatory Bowel Diseases|January 24, 2018
Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014Lone Larsen, Asbjørn Mohr Drewes, Marie Christine Hede Broberg, et al.
European Heart Journal|January 9, 2013
Familial clustering of myocardial infarction in first-degree relatives: a nationwide studyMia Nielsen, Charlotte Andersson, Thomas A Gerds, et al.
Clinical Pharmacology and Therapeutics|November 10, 2018
Hemodynamic Effects of Intravenous, High-Dose Lipid Emulsion With and Without Metoprolol Infusion in Healthy Volunteers: A Randomized Clinical TrialKasper Meidahl Petersen, Søren Bøgevig, Tonny Studsgaard Petersen, et al.
Plos One|January 4, 2013
Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Jesper Lindhardsen, et al.
European Journal of Clinical Pharmacology|November 3, 2019
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilarsThomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
JAMA Internal Medicine|April 1, 2020
Shift From Adalimumab Originator to Biosimilars in DenmarkThomas Bo Jensen, Seoyoung C Kim, Espen Jimenez-Solem, et al.
Journal of Diabetes Investigation|February 3, 2022
Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A subgroup analysis by baseline variables in the PIONEER 9 and PIONEER 10 trialsDaisuke Yabe, Srikanth Deenadayalan, Hiroshi Horio, et al.
The Bone & Joint Journal|September 30, 2021
Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort studyAstrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, et al.
Basic & Clinical Pharmacology & Toxicology|October 14, 2020
Validation of registration of pharmacological treatment in the Danish Hip and Knee Arthroplasty RegistersAstrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, et al.
Scientific Reports|March 7, 2020
Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 yearsDitte Resendal Gotfredsen, Siri Vinther, Tonny Studsgaard Petersen, et al.
Inflammatory Bowel Diseases|January 24, 2018
Changing Infliximab Prescription Patterns in Inflammatory Bowel Disease: A Population-Based Cohort Study, 1999-2014Lone Larsen, Asbjørn Mohr Drewes, Marie Christine Hede Broberg, et al.
European Heart Journal|January 9, 2013
Familial clustering of myocardial infarction in first-degree relatives: a nationwide studyMia Nielsen, Charlotte Andersson, Thomas A Gerds, et al.
Clinical Pharmacology and Therapeutics|November 10, 2018
Hemodynamic Effects of Intravenous, High-Dose Lipid Emulsion With and Without Metoprolol Infusion in Healthy Volunteers: A Randomized Clinical TrialKasper Meidahl Petersen, Søren Bøgevig, Tonny Studsgaard Petersen, et al.
Plos One|January 4, 2013
Hormone replacement therapy and risk of new-onset atrial fibrillation after myocardial infarction--a nationwide cohort studyDitte-Marie Bretler, Peter Riis Hansen, Jesper Lindhardsen, et al.
European Journal of Clinical Pharmacology|November 3, 2019
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilarsThomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder, et al.
Pageof 3